While both drugs share the same active ingredient, their positioning, pricing, and regulatory pathways diverge sharply, ...
Novo Nordisk announced today that Health Canada has issued marketing authorization with conditions [Notice of Compliance with ...
Novo Nordisk has the potential to maintain more consistent revenue growth throughout next year. There is an indication that ...
Flu cases are soaring across Ireland, with hospital admissions under serious pressure, as the HSE warns there’s still no peak ...
In the midst of regulatory and political upheaval, biopharma’s R&D engine kept running, churning out highs and lows in equal ...
Novo Nordisk ($NVO) announced an update on their ongoing clinical study. Study Overview: Novo Nordisk is conducting a study titled WEgovy Real ...
GLP-1s for weight loss may not affect the risk of obesity-related cancers either way, an analysis of the existing evidence ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback